Search research articles
Contact Us
Filters
Showing results (51-60 of 98) with videos related to
Page
of 10
Sort By:
Diabetes
|
April 1, 2018
Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy
Robert Martinez, Hussein Al-Jobori, Ali M Ali, et al.
Diabetes
|
September 15, 2018
Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects With Normal Glucose Tolerance
Chris Shannon, Aurora Merovci, Juan Xiong, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 18, 2018
Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus
Hussein Al Jobori, Giuseppe Daniele, John Adams, et al.
Diabetes Care
|
January 31, 2024
Empagliflozin Reduces Liver Fat in Individuals With and Without Diabetes
Siham Abdelgani, Ahmed Khattab, John Adams, et al.
Diabetes Care
|
August 27, 2016
Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes
Giuseppe Daniele, Juan Xiong, Carolina Solis-Herrera, et al.
Diabetes
|
December 20, 2013
Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals
Giuseppe Daniele, Roy Eldor, Aurora Merovci, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 13, 2022
Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects
Christopher E Shannon, Aurora Merovci, Marcel Fourcaudot, et al.
BMC Endocrine Disorders
|
August 24, 2019
Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population
Saadallah Iskandar, Ayman Migahid, Dalia Kamal, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 4, 2020
Improved Beta Cell Glucose Sensitivity Plays Predominant Role in the Decrease in HbA1c with Cana and Lira in T2DM
Ali Muhammed Ali, Andrea Mari, Robert Martinez, et al.
Diabetes, Obesity & Metabolism
|
April 29, 2024
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria
Afif Nakhleh, Muhammad Abdul-Ghani, Sivan Gazit, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 98) with videos related to
Sort By:
Page
of 10
Diabetes
|
April 1, 2018
Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy
Robert Martinez, Hussein Al-Jobori, Ali M Ali, et al.
Diabetes
|
September 15, 2018
Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects With Normal Glucose Tolerance
Chris Shannon, Aurora Merovci, Juan Xiong, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 18, 2018
Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus
Hussein Al Jobori, Giuseppe Daniele, John Adams, et al.
Diabetes Care
|
January 31, 2024
Empagliflozin Reduces Liver Fat in Individuals With and Without Diabetes
Siham Abdelgani, Ahmed Khattab, John Adams, et al.
Diabetes Care
|
August 27, 2016
Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes
Giuseppe Daniele, Juan Xiong, Carolina Solis-Herrera, et al.
Diabetes
|
December 20, 2013
Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals
Giuseppe Daniele, Roy Eldor, Aurora Merovci, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 13, 2022
Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects
Christopher E Shannon, Aurora Merovci, Marcel Fourcaudot, et al.
BMC Endocrine Disorders
|
August 24, 2019
Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population
Saadallah Iskandar, Ayman Migahid, Dalia Kamal, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 4, 2020
Improved Beta Cell Glucose Sensitivity Plays Predominant Role in the Decrease in HbA1c with Cana and Lira in T2DM
Ali Muhammed Ali, Andrea Mari, Robert Martinez, et al.
Diabetes, Obesity & Metabolism
|
April 29, 2024
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria
Afif Nakhleh, Muhammad Abdul-Ghani, Sivan Gazit, et al.
Page
of 10